Study shows opioid use among US patients with knee osteoarthritis costs 14 billion dollars in societal costs

Although guidelines do not recommend use of opioids to manage pain for individuals with knee osteoarthritis, a recent study published early online in


Arthritis Care & Research


, an official journal of the American College of Rheumatology and the Association of Rheumatology Professionals, estimates that 858,000 Americans use opioids such as tramadol and oxycodone for their knee pain, equating to $14 billion in lifetime opioid-related societal costs, or nearly $0.5 billion annually.

A team led by Elena Losina, PhD, Robert W. Lovett Professor of Orthopedic Surgery, of Brigham and Women’s Hospital, used a computer simulation to estimate the annual and lifetime contribution of opioids to knee osteoarthritis-related costs. The researchers show the direct medical cost of knee osteoarthritis treatment including opioids totals $7.45 billion or 53 percent of the total lifetime costs. The remaining 47 percent of lifetime costs to society is used to pay for lost productivity at work, criminal justice expenses due to opioid use disorders among patients with knee osteoarthritis and cost associated with diversion activities related to illicit use by others.

For an individual patient who used opioids to treat their knee osteoarthritis, the lifetime opioid-related cost was estimated at $13,770. “Given larger number of patients with knee osteoarthritis using opioids, our results provide additional evidence of the substantial economic burden of opioid use for knee osteoarthritis pain management and the potential savings from preventing opioid use,” said Dr. Losina.

The results reveal a substantial economic burden of opioid use among patients with knee osteoarthritis, and they indicate that substantial savings can result from following current guidelines recommending against such use.

“The most important part of our study is that we estimated that almost half of the total societal cost of opioid use in persons with symptomatic knee osteoarthritis is used to pay for lost work productivity and criminal justice and other consequences of the diversion of prescribed opiates to unlawful use,” concludes Dr. Losina. “These data offer new evidence of the magnitude of the societal burden generated by opioid use and misuse and could be used to educate health care providers and health policy decision makers on the best alternatives to opiate use.”

###

Additional Information

NOTE:

The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact:

Dawn Peters +1 781-388-8408 (US)


[email protected]

Follow us on Twitter

@WileyNews

Full Citation:

“Societal cost of opioid use in symptomatic knee osteoarthritis patients in the United States.” Jamie L. Huizinga, Elizabeth E. Stanley, James K. Sullivan, Shuang Song, David J. Hunter, A. David Paltiel, Tuhina Neogi, Robert R. Edwards, Jeffrey N. Katz, and Elena Losina.

Arthritis Care & Research

; Published Online: February 25, 2021 (DOI: 10.1002/acr.24581).

URL Upon Publication:


http://doi.

wiley.

com/

10.

1002/

acr.

24581

Author Contact:

Haley Bridger, of the Brigham and Women’s Media Relations Office, at

[email protected]

or +1 617-525-6383.

About the Journal

Arthritis Care & Research

is an official journal of the American College of Rheumatology (

ACR

) and the Association of Rheumatology Professionals (ARP), a division of the College.

Arthritis Care & Research

is a peer-reviewed journal that publishes both original research and review articles that promote excellence in the clinical practice of rheumatology. Relevant to the care of individuals with arthritis and related disorders, major topics are evidence-based practice studies, clinical problems, practice guidelines, health care economics, health care policy, educational, social, and public health issues, and future trends in rheumatology practice. The journal is published by >

Wiley

on behalf of the

ACR

. For more information, please visit the journal home page at

http://wileyonlinelibrary.

com/

journal/

acr

.

About Wiley

Wiley

drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company’s website can be accessed at

https:/

/

www.

wiley.

com

.